HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

pilose antler peptide

has inflammatory role in LPS-induced lung injury

Also Known As:

PAP peptide

Networked: 10 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 84029
  - pilose antler peptide: 10

Experts

1.	Ding, Yuling: 1 article (08/2023)
2.	Li, Xue: 1 article (08/2023)
3.	Li, Yong: 1 article (08/2023)
4.	Lin, Zhe: 1 article (08/2023)
5.	Liu, Wei: 1 article (08/2023)
6.	Sun, He: 1 article (08/2023)
7.	Xiao, Dandan: 1 article (08/2023)
8.	Bao, Tianping: 1 article (01/2019)
9.	Chen, Huaiping: 1 article (01/2019)
10.	Liu, Xiangye: 1 article (01/2019)

Related Diseases

1.	Non-alcoholic Fatty Liver Disease 05/01/2018 - "This study was performed to investigate the action of pilose antler peptide (PAP) on high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD) in rats. "
2.	Lung Injury 06/01/2017 - "Anti-inflammatory Role of Pilose Antler Peptide in LPS-Induced Lung Injury." 06/01/2017 - "The present study was designed to investigate the effects of pilose antler peptide (PAP) on lipopolysaccharide (LPS)-induced lung injury. "
3.	Fibrosis (Cirrhosis) 01/01/2019 - "The aim of present study was to evaluate the effects of the pilose antler peptide (PAP) on bleomycin (BLM)-induced lung fibrosis. "
4.	Brain Ischemia (Cerebral Ischemia) 09/01/2017 - "The purpose of the current study was to detect the effect of pilose antler peptide (PAP) on cerebral ischemia and explore its potential mechanism. " 09/01/2017 - "Protective effect of pilose antler peptide on cerebral ischemia/reperfusion (I/R) injury through Nrf-2/OH-1/NF-κB pathway."
5.	Neoplasms (Cancer) 11/01/2005 - "Their cytotoxicity against HLA-A24+ cancer cells was dependent on PAP peptide-specific and CD8+ T cells. " 11/01/2005 - "In addition, we examined whether cancer-reactive cytotoxic T lymphocytes (CTLs) could be induced from peripheral blood mononuclear cells (PBMCs) of human leukocyte antigen (HLA) A24+ nonprostate cancer patients by in vitro stimulation with a PAP peptide. " 07/01/1998 - "The obtained PAP-peptide-specific CTL lysed peptide-coated target cells, vaccinia-infected target cells, and HLA-A2-positive prostate-tumor cells in vitro in an antigen-specific manner. "

Related Drugs and Biologics

1.	Lipopolysaccharides
2.	Bleomycin (Blenoxane)
3.	Peptides (Polypeptides)
4.	Amyloidogenic Proteins
5.	p38 Mitogen-Activated Protein Kinases
6.	Matrix Metalloproteinases (MMPs)
7.	HLA Antigens (Human Leukocyte Antigens)
8.	Epidermal Growth Factor (EGF)
9.	Antigens
10.	Amyloid (Amyloid Fibrils)